Humanoid successfully demonstrated its HMND 01 Alpha wheeled mobile manipulator at a Siemens production facility in Germany.

Pipeline advances in 2026 span a range of dermatology disease areas, including atopic dermatitis, hidradenitis suppurativa, and alopecia areata, with 3 ongoing PoC/Phase II clinical studies* and 3 ...

A form of very low-calorie fasting-mimicking diet may help alleviate symptoms of mild-to-moderate Crohn's disease.

Microsoft alone runs approximately 100,000 A/B tests each year to continuously optimize products. A famous Gmail experiment, ...

The successful test is a proof-of-concept for Overview Energy's plans to deliver solar energy to Earth from satellites. The ...

By leveraging inference-time scaling and a novel "reflection" mechanism, ALE-Agent solves the context-drift problems that ...

The Science and Technology Directorate (S&T) is developing a new contactless vessel stopping technology for the U.S. Coast ...

New York and New Jersey regional transportation agencies announced they are partnering to launch a transit competition to ...

Introduction Visual Hallucinations (VHs) (seeing things that others do not, or visions) are a common feature of psychosis, causing significant distress and disability. Services rarely ask about these ...

In conjunction with the strategic evolution, the Company appointed Jian Irish, Ph.D., M.B.A., as Chief Executive Officer. Based on a revised capital allocation strategy, the Company extended its ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it has ...

Port Authority of New York and New Jersey (PANYNJ), New York City Department of Transportation (NYC DOT), and Partnership ...